SC144 is an orally active, small molecule gp130 inhibitor with high potency against human ovarian cancers without toxicity to normal tissues, and this was achieved by binding to gp130 that abrogated subsequent STAT3 activation (66). Here, STAT3 is linked to ovarian carcinoma.